Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Crixivan

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
Patients with schizophrenia are at significantly increased risk for infection with human immunodeficiency virus (HIV), hepatitis… Expand
Is this relevant?
2000
2000
Recent results from human clinical trials have established the critical role of HIV protease inhibitors in the treatment of… Expand
Is this relevant?
1999
1999
Indene is oxidized to mixtures of cis- and trans-indandiols and related metabolites by Pseudomonas putida and Rhodococcus sp… Expand
Is this relevant?
Review
1999
Review
1999
The new phase of North-South research collaboration was caught in a snapshot published recently in a popular weekly newsmagazine… Expand
Is this relevant?
1999
1999
A French study confirms recent reports of hair loss in men as a side effect of the protease inhibitor Crixivan (Indinavir). All… Expand
Is this relevant?
Review
1998
Review
1998
History tells us that when given a reasonably active lead compound, medicinal chemists usually are able to increase the potency… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Indinavir (IDV) (also called CRIXIVAN, MK-639, or L-735,524) is a potent and selective inhibitor of the human immunodeficiency… Expand
Is this relevant?
1996
1996
  • MMWR. Morbidity and mortality weekly report
  • 1996
  • Corpus ID: 25134566
In 1995 and 1996, the Food and Drug Administration (FDA) approved three products in the new protease inhibitor class of drugs… Expand
Is this relevant?
1996
1996
The Food and Drug Administration (FDA) approved two new protease inhibitors for treatment of AIDS. Ritonavir (Norvir) and… Expand
Is this relevant?
1996
1996
Merck's protease inhibitor, indinavir, has received Food and Drug Administration (FDA) approval, and is being made available… Expand
Is this relevant?